Skip Navigation

Cardiovascular Research 1999 43(2):426-436; doi:10.1016/S0008-6363(99)00120-0
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ribadeau-Dumas, A.
Right arrow Articles by Boheler, K. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ribadeau-Dumas, A.
Right arrow Articles by Boheler, K. R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) gene products are regulated post-transcriptionally during rat cardiac development

Antoine Ribadeau-Dumasa, Marc Bradyb, Samuel Y Boatengb, Ketty Schwartza and Kenneth R Bohelerb,c,*

aUnité INSERM UR 153, Institut de Myologie, Groupe Hospitalier Pitié-Salpétrière, Paris, France
bImperial College of Science, Technology and Medicine, National Heart and Lung Institute, London, UK
cNational Institute of Health, National Institute on Aging, Baltimore, USA

* Corresponding author. Tel.: +1-410-558-8095; fax: +1-410-558-8150 bohelerR{at}gre.nia.nih.gov

Objective: The Sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA2) plays a major role in the contraction–relaxation cycle and is responsible for transporting calcium into the lumen of the sarcoplasmic reticulum. This study was performed to determine if the increase in SERCA2 messenger RNA (mRNA) abundance during the perinatal period is regulated transcriptionally. Methods: Transcriptional activity was determined by nuclear run-on assays and mRNA and protein abundances were determined during late fetal and early neonatal cardiac development in rat. Results: From nuclear run-on assays, SERCA2 gene transcription at 17/18 embryonic days (139±41 parts per million (ppm), n=7) did not differ from that at 20 neonatal days (139±37 ppm, n=6) after birth. No increase in transcriptional activity could be demonstrated during the time frame examined. In contrast, both alpha and beta myosin heavy chains showed significant changes in measured transcriptional activity. SERCA2 mRNA normalized to 18S RNA levels are very low in the fetus (9.8±1.9 to 13.4±4.9 arbitrary units (A.U.) from 17/18 to 19/20 embryonic days) and significantly increase from birth (15±3.8 A.U.) to reach a maximum at 20 days of age (29.1±9.5 to 48.3±7.0 in 15 to 20 neonatal days rats respectively). Similarly, SR Ca2+-ATPase protein levels are less abundant in the fetus (0.82±0.08 to 1.13±0.13 A.U./µg total protein) and reach a maximum at 15–20 neonatal days (3.08±0.58 to 2.98±0.17). Ca2+ uptake in the fetal heart is about one sixth the level seen in the adult, reaches the highest observed value at 5 days after birth (6.05±0.77 pmole Ca2+per µg/min) and remains relatively constant over the next 15 days. The activity increases even though phospholamban protein increases in abundance. Conclusions: Since the transcriptional activity of this gene is unchanged whereas the mRNA, protein abundance and activity increase, we conclude that the abundance of SERCA2 gene products is regulated primarily through post-transcriptional mechanisms during the perinatal period.

KEYWORDS Sarco(endo)plasmic reticulum Ca2+-ATPase; Heart development; Rat; Gene transcription; RNA


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. Amir, X. Ma, V. M. Reddy, F. L. Hanley, O. Reinhartz, C. Ramamoorthy, and R. K. Riemer
Dynamics of Human Myocardial Progenitor Cell Populations in the Neonatal Period
Ann. Thorac. Surg., October 1, 2008; 86(4): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Shimura, S. Minamisawa, H. Takeshima, Q. Jiao, Y. Bai, S. Umemura, and Y. Ishikawa
Sarcalumenin alleviates stress-induced cardiac dysfunction by improving Ca2+ handling of the sarcoplasmic reticulum
Cardiovasc Res, January 15, 2008; 77(2): 362 - 370.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Pavlovic, A. Schaller, B. Steiner, P. Berdat, T. Carrel, J.-P. Pfammatter, R. A. Ammann, and S. Gallati
Gender Modulates the Expression of Calcium-Regulating Proteins in Pediatric Atrial Myocardium
Experimental Biology and Medicine, December 1, 2005; 230(11): 853 - 859.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Blum, A. M. Samarel, and R. Mestril
Phosphorylation and binding of AUF1 to the 3'-untranslated region of cardiomyocyte SERCA2a mRNA
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2543 - H2550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. C. Heidkamp, B. T. Scully, K. Vijayan, S. J. Engman, E. L. Szotek, and A. M. Samarel
PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes
Am J Physiol Cell Physiol, August 1, 2005; 289(2): C471 - C482.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Brady, M. U Koban, K. A Dellow, M. Yacoub, K. R Boheler, and S. J Fuller
Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes
Cardiovasc Res, November 1, 2003; 60(2): 347 - 354.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Seki, M. Nagashima, Y. Yamada, M. Tsutsuura, T. Kobayashi, A. Namiki, and N. Tohse
Fetal and postnatal development of Ca2+ transients and Ca2+ sparks in rat cardiomyocytes
Cardiovasc Res, June 1, 2003; 58(3): 535 - 548.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. C. Fijnvandraat, A. C.G. van Ginneken, P. A.J. de Boer, J. M. Ruijter, V. M. Christoffels, A. F.M. Moorman, and R. H. Lekanne Deprez
Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of the embryonic heart tube
Cardiovasc Res, May 1, 2003; 58(2): 399 - 409.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Y. Boateng, R. U. Naqvi, M. U. Koban, M. H. Yacoub, K. T. MacLeod, and K. R. Boheler
Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1029 - H1038.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M.J.B. van den Hoff and A.F.M. Moorman
Measure is treasure
Cardiovasc Res, August 1, 1999; 43(2): 288 - 290.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ver Heyen, S. Heymans, G. Antoons, T. Reed, M. Periasamy, B. Awede, J. Lebacq, P. Vangheluwe, M. Dewerchin, D. Collen, et al.
Replacement of the Muscle-Specific Sarcoplasmic Reticulum Ca2+-ATPase Isoform SERCA2a by the Nonmuscle SERCA2b Homologue Causes Mild Concentric Hypertrophy and Impairs Contraction-Relaxation of the Heart
Circ. Res., October 26, 2001; 89(9): 838 - 846.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.